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We have isolated and characterized Xenopus Mxi1, a member of the Myc/Max/Mad family of bHLHZip transcription factors. Xmxi1
transcripts are present during gastrulation and early neurula stages, earlier and in broader domains as compared to the neuronal determination
factor neurogenin (X-ngnr-1). Consistent with an early role in neurogenesis, Xmxi1 is positively regulated by Sox3, SoxD, and proneural genes, as
well as negatively by the Notch pathway. Loss-of-function experiments demonstrate an essential role for Xmxi1 in the establishment of a mature
neural state that can be activated by factors that induce neuronal differentiation, such as SoxD and X-ngnr-1. Overexpression of Xmxi1 in Xenopus
embryos results in ectopic activation of Sox3, an early pan-neural marker of proliferating neural precursor cells. Within the neural plate, the
neuronal differentiation marker N-tubulin and cell cycle control genes such as XPak3 and p27(Xic1) are inhibited, but the expression of early
determination and differentiation markers, including X-ngnr-1 and X-MyT1, is not affected. Inhibition of neuronal differentiation by Xmxi1 is
only transient, and, at early tailbud stages, both endogenous and ectopic neurogenesis are observed. While Xmxi1 enhances cell proliferation and
apoptosis in the early Xenopus embryo, both activities appear not to be required for the function of Xmxi1 in primary neurogenesis.
© 2005 Elsevier Inc. All rights reserved.Keywords: Xenopus; Primary neurogenesis; Mad; Myc; SoxIntroduction
In Xenopus, the genetic pathway of primary neurogenesis is
activated during gastrulation within a field of undifferentiated
cells in the induced neuroectoderm, giving rise to three
longitudinal domains of neurons on each side of the dorsal
midline (Lamborghini, 1980). Genetic and molecular studies
have identified several proneural factors that participate in the
conversion of neural precursors into fully differentiated
neurons. Most proneural genes exhibit coordinated expression
in three bilateral stripes, thereby defining a synexpression
group. The temporal order of activation of these regulators
represents the successive stages of neuronal determination and⁎ Corresponding author. Abt. Entwicklungsbiochemie, Universität Göttingen,
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doi:10.1016/j.ydbio.2005.12.037differentiation. The earliest gene to be expressed specifically in
the domains of primary neurogenesis is the neuronal determi-
nation factor neurogenin-related-1 (X-ngnr-1) followed by
downstream proneural transcription factors such as X-MyT1,
XCoe2 (Ebf2), XEbf3, and NeuroD (Ma et al., 1996; Bellefroid
et al., 1996; Dubois et al., 1998; Pozzoli et al., 2001; Lee et al.,
1995). In addition, several cell cycle regulators have recently
been identified in this synexpression group, including XPak3,
p27(Xic1), and Gadd45-γ (Souopgui et al., 2002; Carruthers et
al., 2003; Vernon et al., 2003; de la Calle-Mustienes et al.,
2002). In contrast to the genetic hierarchy that operates
downstream of X-ngnr-1, those that follow neural induction
and lead to both the maturation and maintenance of the neural
precursor population, as well as control the selection of the
proneural territories are not well defined. However, several
genes have been implicated in this process, including members
of the Sox, Xiro, and Zic transcription factor families (Moody,
2005).
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regulate a variety of cellular functions including proliferation,
differentiation, and apoptosis. Proteins of this network are
characterized by a conserved basic helix–loop–helix–leucine
zipper (bHLHZip) domain that facilitates DNA binding and
protein dimerization (Grandori et al., 2000; Zhou and Hurlin,
2001). In general, Myc positively regulates cell proliferation,
and the deregulated expression of Myc plays a significant role in
the development of human cancers (Nilsson and Cleveland,
2003). To bind regulatory elements of target genes and to elicit
its cellular effects, Myc requires heterodimerization with Max
(Grandori et al., 2000; Zhou and Hurlin, 2001). Transcriptional
activation of target genes is mediated by association of
coactivators to conserved motifs in the N-terminus of Myc.
Max also forms heterodimers with the members of the Mad
family (Ayer et al., 1993; Zervos et al., 1993; Hurlin et al.,
1995). The Mad proteins (Mad1, Mxi1, Mad3, and Mad4), and
the larger and distantly related Mnt (also termed Rox), can
antagonize the transforming activity of Myc by sequestering
Max, as well as through the binding and repression of a subset
of Myc-target genes (Baudino and Cleveland, 2001; O'Hagan et
al., 2000; Hurlin et al., 1997; Meroni et al., 1997). Active
repression is achieved by recruitment of complexes containing
histone deacetylases to the N-terminal SID domain found in the
Mad proteins (Schreiber-Agus et al., 1995; Rao et al., 1996;
Alland et al., 1997; Hassig et al., 1997; Laherty et al., 1997).
Extensive evidence demonstrating that Mxi1 and other
members of the Mad family can induce growth arrest and inhibit
Myc transformation has been obtained by experiments
performed in cell culture systems. However, studies elucidating
the functional role of the Mads in normal differentiation
processes and in embryonic development remain unclear, as
does their contribution to Myc antagonism. Several recent
reports have demonstrated that members of the Myc/Mad/Max
network can directly control cell fate determination through a
mechanism that is independent of proliferation and apoptosis.
For example, c-Myc has been shown to be required for neural
crest specification in Xenopus, and Mad1 has been identified as
a direct activator of the PDX-1 gene in pancreatic β-cells
(Bellmeyer et al., 2003; Patane et al., 2003).
Presently, we report on the isolation and characterization of a
novel member of the Mad family of transcriptional repressors in
Xenopus, Xmxi1. In gastrula and open neural plate stage
embryos, the expression of Xmxi1 coincides with the territories
of primary neurogenesis, with Xmxi1 exhibiting earlier and
broader expression domains as compared to X-ngnr-1. We
demonstrate that Xmxi1 is an essential component of the
neurogenesis cascade functioning prior to X-ngnr-1, but
downstream of SoxD. In addition, Xmxi1 loss-of-function
experiments in animal cap explants demonstrate that ectopic
neuralization induced by X-ngnr-1 overexpression is incom-
plete, as shown by the absence of the pan-neural marker
NCAM. This may contribute to the failure of X-ngnr-1 to
induce neuronal differentiation in the presence of an Xmxi1
antisense morpholino. In gain-of-function studies, Xmxi1 was
demonstrated to participate in the establishment and mainte-
nance of the early neuronal precursor identity through theactivation of Sox3. The induction of Sox3 expression occurred
concomitantly with inhibition of neuronal differentiation. The
inhibition of neuronal differentiation by Xmxi1 was only
transient, and, at early tailbud stages, both endogenous and
ectopic N-tubulin expression were observed.
Materials and methods
Isolation of Xmxi1
A Xenopus tadpole head λZAP phage cDNA library was used in a large-
scale whole-mount in situ hybridization screen as described (Souopgui et al.,
2002). The isolated Xmxi1 clone in pBKCMV contained 1314 bp of the 3′-
UTR. Rescreening of the library by ECL Direct Nucleic Acid Labeling and
Detection System (Amersham Bioscience) afforded a clone with a 2778 bp
insert containing the entire coding sequence of Xmxi1, 72 bp of 5′-UTR, and
1891 bp of 3′-UTR including the polyA tail.
Constructs
Xmxi1 and Xmax constructs were prepared by PCR amplification and
subcloned into pCS2+ or its derivatives. Human Bcl2 (aa 1–240) was subcloned
into EcoRI sites of pRN3. MT-Xmxi1-DBMpCS2 was generated by the
QuickChange™XL Site-Directed Mutagenesis Kit (Stratagene) using the
following primers: up, 5′-CCCACGAACTGGCGAAGAACCGGAGAGCC-
3′ and lower 5′-GGCTCTCCGGTTCTTCGCCAGTTCATTGTGGG-3′, muta-
tion underlined.
Embryo culture and microinjections
Embryos were obtained from Xenopus laevis by HCG-induced egg-laying
using standard techniques and staged according to Nieuwkoop and Faber
(1967). Capped mRNA for microinjections was in vitro transcribed (mMessage-
mMachine™ Ambion) and purified over an RNeasy column (Qiagen). Enzymes
used for linearization and transcription, as well as the amount of mRNA injected
are indicated: MT-Xmxi (NotI, SP6, 500–750 pg); MT-XMad1 (NotI, SP6, 500
pg); human Bcl2 (SfiI, T3, 500 pg); Xmxi1-GR, MT-Xmxi1-DBM, EnR-Xmxi1,
Max (SacII, SP6, 500 pg). The following constructs were previously described:
Noggin (50 pg, Smith et al., 1993); Notch-ICD (50 pg, Coffman et al., 1993);
MT-X-ngnr-1 (25 pg, Ma et al., 1996); NeuroD (500 pg, Lee et al., 1995); SoxD
(200 pg, Mizuseki et al., 1998); NLS LacZ (50 pg Chitnis et al., 1995); and DN-
Su(H) (300 pg, Wettstein et al., 1997). For coinjection experiments, GFP mRNA
was used to normalize the mRNA concentrations. As a lineage tracer, 50 pg
nuclear lacZ mRNAwas coinjected. Embryos were injected in one blastomere of
the two-cell stage for mRNA injections. Antisense morpholinos were obtained
from Gene Tools LLC. Standard control-MO (Co-MO): 5′-CCTCTTACCT-
CAGTTACAATTTATA-3′; Xmxi1-MO 5′-ATCCACCAGCTCCACCGACTC-
TAAT-3′; MM-Xmxi1-MO 5′-ATGCACGAGCTGCACCCACTGTAAT-3′;
Xmxi1-MO2 5′-TCCATCATCTCCTGCAGCTCCATCA-3′; X-ngnr-1-MO
5′-TGGTTAGCCCCAATGTTGCACTGAC-3. For in vitro and in vivo MO
specificity experiments, see Supplementary Material.
Chemical treatment of embryos
Embryos were incubated with dexamethasone (4 μg/ml in 0.1× MBSH) at
various stages until fixation (Kolm and Sive, 1995). HUA treatment was
performed as described (Hardcastle and Papalopulu, 2000).
Whole-mount in situ hybridization and histology
X-gal staining was performed as described (Hardcastle and Papalopulu,
2000). Whole-mount in situ hybridization was performed essentially as
described (Harland, 1991; Hollemann and Pieler, 1999) using antisense RNA
labeled with digoxygenin-11-UTP. Double in situ hybridization was performed
according to Knecht et al. (1995). Sox3 was labeled with fluorescein and stained
with FastRed (Roche) and Xmxi1 with digoxygenin and NBT/BCIP. Enzymes
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T7); Sox3pBS (EcoRI/T7); and EpiKpGEM-T (XK81) (EcoRI/T7). The
following constructs were previously described: XPak3 (Souopgui et al.,
2002); X-ngnr-1 (Ma et al., 1996); X-MyT1 (Bellefroid et al., 1996); N-tubulin
(Chitnis et al., 1995); NeuroD (Lee et al., 1995); X-Delta1 (Chitnis et al., 1995);
ESR9 (Li et al., 2003); and p27(Xic1) (Ohnuma et al., 1999).
Specimens were embedded in a gelatin/albumin mixture, and sections (30
μm) were cut on a Leica VT1000M vibratome (Hollemann and Pieler, 1999).
Proliferation and TUNEL assays
The BrdU assay was performed as described by Hardcastle and Papalopulu
(2000) with the following exception: undiluted BrdU solution (8 nl) was
bilaterally injected dorsally and once into the ventral hemisphere of stage 15
embryos and fixed 1 h later. The pH3 and TUNEL assays were performed as
described (Dent et al., 1989; Hensey and Gautier, 1997).
Animal cap dissections and real-time RT-PCR
Two-cell stage embryos were injected bilaterally, animal caps dissected from
stage 8 to 9 embryos and cultured until sibling controls reached the desired
stage. Total RNA was prepared with RNAqueous-Micro Kit (Ambion). cDNA
was prepared using random hexamer primers in 100 μl total volume containing
500 ng of total RNA, and a 5 μl aliquot was assayed in a total volume of 50 μl by
real-time PCRwith iQ Sybr Green Supermix in the iCycler system (BioRad). All
samples were normalized to levels of ornithine decarboxylase (ODC), which
was used as the loading control. The mRNA concentration was measured by
using a standard curve for each analyzed gene. All measurements were done in
duplicates, and the values in the figures represent the mean of a representative
experiment. For a list of primer sequences and PCR conditions, see
Supplementary Material.Results
Cloning and expression of Xmxi1
In a large-scale expression screen aimed at identifying
novel Xenopus genes in the context of neurogenesis, one
clone exhibited broad expression throughout the territories of
primary neurogenesis (Souopgui et al., 2002). As the isolated
clone did not contain an open reading frame, a Xenopus head
cDNA library was screened, and an overlapping clone
harboring 2778 bp of cDNA sequence was obtained. This
isolated cDNA sequence encoded for a protein of 238 amino
acids containing a SID repressor domain and a bHLHZip
domain characteristic of the Mad family of Myc antagonist
proteins.
We termed our isolated gene Xmxi1 as the deduced
protein sequence was most closely related to other vertebrate
Mxi1 proteins. In mouse and human, three isoforms of Mxi1
have been identified (Fig. 1A) (Dugast-Darzacq et al., 2004;
Engstrom et al., 2004). The most characterized isoform
Mxi1-SRβ is both a strong transcriptional repressor and
growth suppressor. Mxi1-WR is identical to Mxi1-SRβ with
the exception that it does not harbor the N-terminal 36
amino acids encoding for the SID domain and thus lacks
these activities. Mxi1-SRα (also termed Mxi1-O) has an
extended N-terminus and a slightly different SID domain
compared with Mxi1-SRβ. Alignment of the Xenopus
protein and the mouse Mxi1 isoforms revealed an identity
between 58 and 64% over the entire protein, with higherregions of homology found within the SID repressor (70%)
and the bHLH domains (86%) (Fig. 1A). The overall
homology with other mouse members of the Mad family
was much lower (20–50%).
The temporal expression of Xmxi1 was investigated by
RT-PCR analysis with RNA isolated from various stages of
Xenopus development (Fig. 1B). Maternal transcripts of
Xmxi1 were detected at low levels but increased during
gastrula stages and were maintained at constant levels
throughout neurogenesis and later development. The temporal
expression of Xmxi1 was unique in comparison with other
Xenopus members of the Mad family. Transcripts of Xmad1
and Xmad3 are expressed at relatively constant levels during
embryogenesis, while those of Xmnt and Xmad4 decrease
during neurula stages (Juergens et al., 2005; Newman and
Krieg, 1999).
Xmxi1 mRNA was first detected by whole-mount in situ
hybridization analysis broadly throughout the dorsal ectoderm
during gastrulation. The expression of Xmxi1 is very similar to
one of the earliest proneural genes, X-ngnr-1 (Ma et al., 1996).
As shown in Fig. 1C, a direct comparison of their expression
patterns during gastrulation reveals that Xmxi1 expression
domains are much broader and prefigure the domains of
primary neurogenesis demarcated by X-ngnr-1. At stage 13 in
the posterior neural plate, transcripts are localized in three
broad stripes on both sides of the dorsal midline encompassing
the medial, intermediate and lateral proneural domains that
will later give rise to the motor-, inter- and sensory neurons,
respectively (Fig. 1G). Xmxi1 transcripts are also found in
additional cell populations of the anterior neural plate that
express other proneural genes including the trigeminal and
olfactory placodes, as well as cells of the future ventral
midbrain and hindbrain. Double labeling of stage 14 embryos
with Xmxi1 and Sox3, a pan-neural marker expressed in
proliferating cells, showed that their expression domains are
partially overlapping, including the different layers of the
posterior neuroectoderm (Figs. 1D–F). In contrast to Sox3,
Xmxi1 is excluded from the anterior neural plate, a territory in
which neuronal differentiation is delayed until the tadpole
stage (Papalopulu and Kintner, 1996). Moreover, the lateral
stripe of Xmxi1, similar to that of the neuronal differentiation
marker N-tubulin, is outside of the territory stained by Sox3
(Fig. 1E, arrowhead) (Bellefroid et al., 1998). During later
neurula stages, Xmxi1 continued to be broadly expressed
throughout the neural plate but was excluded from the anterior
neural folds (Fig. 1H). A transversal section of a stage 16
embryo revealed that Xmxi1 transcripts are now predominate-
ly restricted in the sensorial layer of the neuroectoderm where
primary neurogenesis occurs (Fig. 1I) (Hartenstein, 1989). At
stage 27, Xmxi1 expression was detected throughout the CNS
including the eye, the olfactory placodes, midbrain, hindbrain,
and spinal cord (Fig. 1K). In a transversal section of a stage 37
embryo, expression of Xmxi1 in the eye was restricted to the
retina (Fig. 1M), while the expression in the neural tube was
located in the proliferating neural progenitors of the ventricular
zone and the intermediate zone, where cells start to
differentiate (Fig. 1N).
Fig. 1. (A) Comparison of the predicted amino acid sequence of Xmxi1 with the mouse Mxi1 isoforms. GenBank accession number Xmxi1: DQ137875. (B) RT-PCR
analysis of Xmxi1 at different stages of development. Histone H4 was used as a loading control. (C) Whole-mount in situ hybridization expression analysis of Xmxi1
in comparison with X-ngnr-1. (D–F) Double labeling of Xmxi1 and Sox3 expression. Sox3, red; Xmxi1, dark blue. (D) Stage 14, anterior view. (E) Stage 14, dorsal
view. White arrowhead marks the lateral stripe of Xmxi1. (F) Transversal section of E. (G–N) Spatial expression of Xmxi1 during later stages of Xenopus
development. (G) Stage 13, dorsal, anterior up. (H) Stage 16, dorsal view, anterior left. (I) S1 transversal section. (J) Stage 22, lateral. (K) Stage 27, anterior (L) Stage
37, lateral. (M) S2 transversal section. (N) S3 transversal section, dark brown staining at the roof of the spinal chord is pigmentation not Xmxi1 staining. el, epithelial
layer; hb, hindbrain; i, intermediate; iz, intermediate zone; l, lateral; le, lens; m, medial; mb, midbrain; n, notochord; op, olfactory placode, r, retina; sl, sensory layer; st,
stage; tg, trigeminal placodes; vz, ventricular zone.
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An early role for Xmxi1 in the regulation of primary
neurogenesis is strongly suggested by both the temporal and
spatial expression of Xmxi1. To study the regulation of Xmxi1,
known positive and negative regulators of neurogenesis were
evaluated for their influence on Xmxi1 expression in whole
embryos. mRNAs encoding regulatory factors were injected
into one blastomere of two-cell stage embryos together with
LacZ mRNA to localize the distribution of the injected mRNA.
As shown in Figs. 2A and B, the pan-neural HMG-box
transcription factor Sox3 ectopically activates Xmxi1 expres-Fig. 2. (A–J) Regulation and requirement of Xmxi1 during primary neurogenesis. Wh
X-ngnr-1 (50 pg), NeuroD (500 pg), Notch-ICD (50 pg), or DN-Su(H) (300 pg), as in
the lower left hand corner. The injected side (β-gal, light blue) is on the right, and em
expression (A, C) or the increased density of the lateral stripe (I, J). (K) Xmxi1 is a
analysis of animal caps isolated from embryos injected with noggin (50 pg), X-ngnr
control. CC, control caps; CE, control embryos. (L, M) N-tubulin expression of st
indicated in the upper right hand corner. (N) SoxD activation of Xmxi1 does not requ
pg), X-ngnr-1-MO (15 ng), X-ngnr-1 (25 pg), and control-MO (Co-MO) (15 ng), as in
RT-PCR analysis. Expression levels were normalized to ornithine decarboxylase (OD
that X-ngnr-1 RT primers detect both endogenous and injected X-ngnr-1 RNA.sion (96%, n = 23), while it inhibits the neuronal differentiation
marker, N-tubulin (92%, n = 60). X-ngnr-1 also ectopically
activates Xmxi1 expression (100%, n = 37), which is similar to
its effect on N-tubulin (Figs. 2C, D). The downstream proneural
transcription factor NeuroD also strongly induces Xmxi1 within
the neural plate, as well as in the nonneural ectoderm (87%,
n = 45) (Fig. 2E).
In addition to its proneural activity, X-ngnr-1 activates the
Notch pathway, which restricts the number of cells that undergo
neuronal differentiation. To determine the influence of Notch
signaling on the expression of Xmxi1, Notch signaling was
increased or decreased by overexpression of the intracellularole-mount in situ hybridization of stage 14 embryos injected with Sox3 (50 pg),
dicated in the upper right hand corner. The antisense probes used are indicated in
bryos are shown as a dorsal view, anterior down. Red arrowhead marks ectopic
ctivated by X-ngnr-1 and SoxD, but not by the neural inducer noggin. RT-PCR
-1 (25 pg), and SoxD (200 pg), as indicated. Histone H4 was used as a loading
age 14 embryos injected with X-ngnr-1-MO (15 ng) and X-ngnr-1 (25 pg), as
ire X-ngnr-1. Animal caps were isolated from embryos injected with SoxD (200
dicated, cultured until sibiling embryos reached stage 14 and subject to real-time
C) and compared to the induction capacity of SoxD, which was set to 10. Note
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version of X-Su(H) mutated in the DNA binding domain
(DN-SuH) (Chitnis et al., 1995; Wettstein et al., 1997). Injection
of mRNA encoding Notch-ICD negatively regulated Xmxi1
(96%, n = 24) expression, as well as X-ngnr-1 (Figs. 2G, H).
Conversely, DN-SuH increased the density of Xmxi1 (92%,
n = 27) and X-ngnr-1 in the domains of primary neurogenesis
(Figs. 2I, J). These results demonstrate that Xmxi1 is negatively
regulated by lateral inhibition.
The regulation of Xmxi1 was also investigated in ectodermal
explants (animal caps) from blastula stage embryos; these
explants are normally fated to become epidermal tissue but can
be converted to derivatives of all three germ layers. The animal
blastomeres of two-cell stage Xenopus embryos were injected
bilaterally with mRNA, and animal caps were dissected at
blastula stage. Total RNAwas isolated at stage 14 and analyzed
by RT-PCR. As shown in Fig. 2K, while animal caps neuralized
with the BMP inhibitor noggin afford a strong induction of the
pan-neural markers Sox3 and NCAM, but Xmxi1 transcript
levels did not significantly increase. While Sox3 overexpression
in whole embryos afforded ectopic activation of Xmxi1 (Fig.
2A), the Sox3 levels induced by noggin maybe insufficient for
activation in animal caps. Consistent with its ability to activate
Xmxi1 in the nonneural ectoderm of whole embryos, X-ngnr-1
robustly activated not only N-tubulin and NCAM, but also
Xmxi1. Interestingly, Sox3 was not induced by X-ngnr-1 in the
animal cap assay, as well as in whole embryos (Fig. 2K and data
not shown). This may reflect the incompatibility with neuronal
differentiation as previously suggested by their mutual
exclusive expression patterns (Bourguignon et al., 1998;
Bellefroid et al., 1998). We also investigated the regulation of
Xmxi1 by SoxD, an early pan-neural transcription factor that
can induce both neural and neuronal differentiation in
ectodermal explants (Mizuseki et al., 1998). As shown in Fig.
2K, SoxD activates Xmxi1, but as overexpression of SoxD also
increases the levels of X-ngnr-1, activation of Xmxi1 may be
indirect (Yeo and Gautier, 2005).
Therefore, we asked if the induction of Xmxi1 transcripts by
SoxD was maintained in the absence of X-ngnr-1. Towards this
end, an antisense morpholino oligonucleotide (MO) that is
expected to inhibit the translation of the endogenous X-ngnr-1
was designed (Heasman, 2002). The X-ngnr-1-MO, but not a
control-MO, inhibited translation of X-ngnr-1 mRNA in an in
vitro coupled transcription/translation reaction (Supplementary
Material). Correspondingly, in whole embryos, the X-ngnr-1-
MO inhibited neuronal differentiation on the injected side (loss
of N-tubulin, 85%, n = 39) (Fig. 2L). The control-MO did not
alter the expression of N-tubulin (data not shown). Moreover,
the loss of N-tubulin expression by the X-ngnr-1-MO could be
rescued by coinjection with X-ngnr-1 mRNA (no loss of N-
tubulin plus ectopic N-tubulin, 100%, n = 110) (Fig. 2M).
As shown by real-time RT-PCR analysis, overexpression of
SoxD alone or in combination with the X-ngnr-1-MO increased
Xmxi1 transcript levels in animal caps to the same extent.
However, as anticipated, the X-ngnr-1-MO, but not the control-
MO, inhibited SoxD induction of N-tubulin (Fig. 2N). This loss
of N-tubulin expression was not due to inhibition of X-ngnr-1transcript levels and could be rescued by coinjection of X-ngnr-
1 mRNA, further demonstrating specificity of the MO. The
above results show that Xmxi1 is regulated by pan-neural and
proneural genes further, supporting an early role for Xmxi1 in
the context of primary neurogenesis.
Xmxi1 is essential for primary neurogenesis
The requirement of Xmxi1 during primary neurogenesis was
evaluated using an MO to inhibit translation of the endogenous
Xmxi1. The specificity of the MO was demonstrated by the
inhibition of translation of an Xmxi1 5′-UTR-GFP fusion
mRNA in Xenopus embryos by the Mxi1-MO, but not a GFP
mRNA lacking the MO target site (Supplementary Material). A
specific control mismatch MO (MM-Xmxi1-MO) did not alter
translation of either RNA.
Injection of the Xmxi-MO (12.5 ng) into one dorsal
blastomere of four-cell stage embryos led to an inhibition of
neuronal differentiation, as marked by N-tubulin (86%, n = 67)
(Fig. 3A). The MM-Xmxi1-MO did not alter N-tubulin
expression (100%, n = 48) (Fig. 3H). The suppression of N-
tubulin by the Xmxi1-MO was not due to the loss of the neural
precursor cell population as Sox3 expression was not
significantly altered (93%, n = 23) (Fig. 3D). However, the
early proneural genes X-ngnr-1 (72%, n = 79) and X-MyT1
(80%, n = 15) were both inhibited by the Xmxi1-MO (Figs.
3B, C). To further demonstrate specificity of the loss-of-
function phenotype, an additional MO (Xmxi1-MO2) was used
which recognizes a different target site. Consistently, the
Xmxi1-MO2 also inhibited expression levels of X-ngnr-1
(71%, n = 76), X-MyT1 (73%, n = 63), and N-tubulin (85%,
n = 79) (Figs. 3E–G).
The loss of X-ngnr-1 expression could be rescued by
coinjection of MT-Xmxi1 (500 pg) together with the morpho-
lino, further demonstrating specificity of the MO (65%, n = 110
of the embryos exhibited no reduction of X-ngnr-1 on the
injected side) (Fig. 3I). However, it should be noted that
attempts to rescue the morpholino-induced inhibition of N-
tubulin by titrating the concentration of Xmxi1 was not
possible, even with doses as low as 5 pg. The failure to rescue
the loss of N-tubulin expression may partially be attributed to
the finding that MT-Xmxi1 overexpression results in a transient
inhibition of neuronal differentiation downstream of X-ngnr-1
(see below).
As SoxD is expressed earlier than Xmxi1 and as SoxD
activates transcription of both Xmxi1 and X-ngnr-1 (Fig. 2K
andMizuseki et al., 1998), we asked if Xmxi1 is required for the
function of SoxD. In whole embryos, overexpression of SoxD
afforded a strong ectopic activation of X-ngnr-1 (ectopic X-
ngnr-1, 90% n = 20) that was effectively inhibited by the
presence of the Xmxi1-MO (ectopic X-ngnr-1 with much
weaker staining than SoxD alone, 30% n = 23) (compare Figs.
3J, K). Moreover, this inhibition could be rescued by
coinjection of MT-Xmxi1 (ectopic X-ngnr-1, 84% n = 19)
(Fig. 3L).
To further provide evidence that Xmxi1 is required for
SoxD function, we used the animal cap assay coupled with
Fig. 3. Xmxi1 is required for primary neurogenesis. (A–L) Whole-mount in situ hybridization of stage 14 embryos injected with Xmxi1-MO (12.5 ng), Xmxi1-MO2
(15 ng), mismatch morpholino MM-Xmxi1-MO (12.5 ng), MT-Xmxi1 (500 pg), or SoxD (200 pg), as indicated in the upper right hand corner. The antisense probes
used are indicated in the lower left hand corner. The injected side (β-gal, light blue) is on the right, and embryos are shown as a dorsal view, anterior down with the
exception of J and L, which are lateral. (M) Xmxi1 is required for SoxD-induced neuronal differentiation. Animal caps were isolated from embryos injected with SoxD
(200 pg), Xmxi1-MO (12.5 ng), Co-MO (12.5 ng), and MT-Xmxi1 (500 pg), as indicated and analyzed by real-time RT-PCR. Expression levels were normalized to
ODC and were compared to the induction capacity of SoxD-injected animal caps, which was set to 10.
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neural markers Nrp-1 and NCAM, as well as X-ngnr-1 and
N-tubulin (Fig. 3M). However, in the presence of the
Xmxi1-MO, but not the control-MO, the activation of X-ngnr-1 by SoxD was significantly inhibited. Consistent with
the results obtained in the whole embryo, the inhibitory
effect of the Xmxi1-MO could be rescued by coinjection of
MT-Xmxi1. In addition, the Xmxi1-MO suppressed the
Fig. 4. Xmxi1 is required for X-ngnr-1-induced neuronal differentiation. Animal
caps were isolated from embryos injected with X-ngnr-1 (20 pg), Xmxi1-MO
(12.5ng),Co-MO(12.5ng), andMT-Xmxi1 (500pg) as indicatedandanalyzedby
real-timeRT-PCR.Expression levelswerenormalized toODCandwerecompared
to the induction capacity of X-ngnr-1-injected animal caps, which was set to 10.
477T.J. Klisch et al. / Developmental Biology 292 (2006) 470–485induction by SoxD of the late pan-neural markers Nrp-1 and
NCAM.
The results obtained thus far argue for a role of Xmxi1
upstream of the proneural genes. However, as shown in Fig. 2C,
X-ngnr-1 ectopically activates Xmxi1, suggesting that Xmxi1
may also have a function downstream of the proneural genes. To
investigate this possibility, we employed the animal cap assay
and real-time RT-PCR analysis. In the presence of the Xmxi1-
MO but not the control-MO, the X-ngnr-1 induction of the
downstream proneural genes (X-MyT1 and NeuroD) and N-
tubulin was inhibited (Fig. 4). However, X-ngnr-1 not only
induces neuronal differentiation mediated by the proneural
genes, but also induces neuralization, as illustrated by the
activation of general pan-neural markers such as Nrp-1 and
NCAM. Interestingly, the Xmxi1-MO slightly reduced activa-
tion of Nrp-1 by X-ngnr-1, but NCAM, which marks the mature
neural cells, was strongly inhibited (Fig. 4) (Sasai, 2001). These
results are consistent with the notion that Xmxi1 is an essential
component of neurogenesis required to obtain a mature neural
state that can respond to factors that induce neuronal
differentiation.
Xmxi1 overexpression delays the process of primary
neurogenesis
To further study the role of Xmxi1 in the context of primary
neurogenesis, gain-of-function experiments in Xenopus embry-
os were performed. As mammalian members of the Myc and
Mad families have been found to exert a short half-life in cell
culture (Hann and Eisenman, 1984; Ayer et al., 1993), we
checked the stability of Mxi1 in Xenopus embryos by injecting
mRNA encoding for Xmxi1 bearing an Myc epitope (MT) at the
N-terminus. Western blot analysis revealed constant protein
levels of MT-Xmxi1 throughout gastrulation and early neurula
stages, but, by stage 20, it is no longer detected (Supplementary
Material).
Injection of MT-Xmxi1 mRNA (500 pg) into the animal pole
of one blastomere at the two-cell stage negatively influenced
neuronal differentiation, as shown by the loss of N-tubulin
expression on the injected side of the embryo (70%, n = 134)
(Fig. 5A). The inhibition of primary neurogenesis was not the
result of loss of the neural precursor pool as Sox3 expression
was not reduced but dramatically expanded and found in the
nonneural ectoderm of the injected side (77%, n = 128) (Fig.
5B). The increase in Sox3 expression occurred at the expense of
epidermis, as shown by the loss of epidermal keratin expression
(72%, n = 22) (Fig. 5C). Thus, Xmxi1 and Sox3 exhibit positive
reciprocal regulation (Figs. 2A, 5B).
As all members of the Mad family have closely related SID
repressor and bHLHZip domains, we therefore asked if the
overexpression phenotype observed is unique to Xmxi1. The
bHLH and SID domains of Xmad1 exhibit 76% and 80%
identity compared to the corresponding domains in Xmxi1, but
the overall homology is much lower (53%). Moreover, in
contrast to Xmxi1, which is found primarily in proliferating
tissue, Xmad1 is predominately found in post-mitotic cells
(Juergens et al., 2005). Several experiments support that the
Fig. 5. Xmxi1 activates ectopic Sox3 and inhibits neuronal differentiation. (A–N) Whole-mount in situ hybridization of stage 14 embryos injected with 500 pg of MT-
Xmxi1, MT-Xmad1, MT-Xmxi1-DBM, EnR-Xmxi1, or Max, as indicated in the upper right hand corner. Antisense probes used are indicated in the lower left hand
corner. The injected side is always on the right, and all embryos are shown as dorsal views, anterior down with the exception of C and N, which are ventral views.
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differentiation by MT-Xmxi1 are most likely not due to an
unspecific activity, such as the binding to non-target E-box
sequences, the sequestration of Max or other bHLH transcrip-
tion cofactors. First, MT-Xmad1 (500 pg) did not alter the
expression of N-tubulin or Sox3 (N-tubulin, 83%, n = 34; Sox3,
83%, n = 18) (Figs. 5D, E). In addition, the activity of Xmxi1
was found to be dependent on its ability to bind DNA.
Overexpression of MT-Xmxi1 containing a point mutation in
the basic domain that is expected to disrupt DNA binding (MT-
Xmxi1-DBM) did not induce ectopic activation of Sox3 and
inhibition of N-tubulin expression (no effect, N-tubulin 86%,
n = 87; Sox3, 82%, n = 93) (Figs. 5F, G) (Fisher et al., 1993;
Prochownik et al., 1998). Moreover, coinjection of MT-Xmxi1
together with Max did not alter the effect of Xmxi1 on primary
neurogenesis (inhibition of N-tubulin, 80%, n = 21, ectopic
Sox3, 76%, n = 21) (Figs. 5H, I).
To determine if the SID repressor domain was required for
Xmxi1 function in the context of primary neurogenesis, the SID
repressor domain was removed. Overexpression of mRNA
encoding MT-ΔNXmxi1 (500 pg) also did not alter the
expression of Sox3 or N-tubulin, demonstrating the necessity
of the repressor domain (no effect, N-tubulin, 92%, n = 25;
Sox3, 80%, n = 50) (Figs. 5J, K). Correspondingly, replacement
of the SID domain with a heterologous repressor domain
derived from Engrailed Repressor (EnR-Xmxi1) (Jaynes and
O'Farrell, 1991) functioned in a similar manner to MT-Xmxi1,
inducing ectopic Sox3 expression concomitant with a loss ofepidermal keratin and N-tubulin expression (Sox3, 70%, n = 46
ectopic; EpiK, 82%, n = 11 reduced; N-tubulin, 78%, n = 32
reduced) (Figs. 5L–N).
Expansion of the neural plate and inhibition of neuronal
differentiation are similar to the phenotype observed upon
activation of Notch signaling (Coffman et al., 1993).
However, the expression patterns of the Notch ligand X-
Delta1 (100%, n = 10) and ESR9 (75%, n = 12), a direct
Notch target gene, were not altered on the side injected with
MT-Xmxi1 mRNA (Figs. 6A, B). In addition, MT-Xmxi1 had
no significant effect on early proneural markers such as X-
ngnr-1 (83%, n = 30), X-MyT1 (78%, n = 32), and NeuroD
(67%, n = 27) (Figs. 6C–E). The EnR-Xmxi1 afforded similar
results as MT-Xmxi1, with the exception that NeuroD was
suppressed in a significant percentage of the embryos (no
change on the injected side, X-Delta1 94%, n = 17; ESR9
74%, n = 19; X-ngnr-1 100%, n = 20, X-MyT1 88%, n = 16
and downregulated on the injected side NeuroD 67%, n = 18)
(Supplementary Material).
As the process of neuronal differentiation is tightly
coupled with cell cycle withdrawal and Xmxi1 ectopically
activates Sox3, a marker that coincides with neural cell
proliferation, the influence of Xmxi1 on the expression of
factors known to regulate cell cycling in the context of
primary neurogenesis was investigated. MT-Xmxi1 inhibited
the expression of p21-activated kinase 3 (XPak3) (82%,
n = 55) and the cdk inhibitor p27(Xic1) (77%, n = 44), which
are required for cell cycle exit and differentiation of primary
Fig. 6. Xmxi1 inhibits genes required for cell cycle withdrawal but does not influence neurogenic and early proneural genes. (A–G)Whole-mount in situ hybridization
of stage 14 embryos injected with 500 pg of MT-Xmxi1. Antisense probes used are indicated in the lower left hand corner. The injected side is always on the right, and
all embryos are shown as dorsal views, anterior down. (H) Transversal section of G. (I) Xmxi1 blocks induction of late, but not early X-ngnr-1-induced target genes in
animal caps. Real-time RT-PCR analysis of animal cap explants isolated from embryos injected with X-ngnr-1 (25 pg) alone or together with MT-Xmxi1 (500 pg).
Expression levels were normalized to ODC and compared to the induction capacity of X-ngnr-1 injected animal caps, which were set to 10.
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2003; Vernon et al., 2003). As shown in the transversal
section in Fig. 6H, MT-Xmxi1 inhibited p27(Xic1) in the
neuroectoderm, as well as in the myotome, suggesting that
this may be a direct effect on p27(Xic1).
The results obtained by the gain-of-function experiments
suggest that Xmxi1 expands the precursor population and
inhibits differentiation events downstream of the early
proneural transcription factors at the open neural plate
stage. To gain additional support for this mechanism of
action by Xmxi1, we employed the animal cap assay in
combination with real-time RT-PCR. Injection of mRNA
encoding for X-ngnr-1 in early cleavage embryos prior to
explant preparation is sufficient to drive this nonneural
ectoderm into differentiated neural tissue (Fig. 6I). Coinjec-
tion of MT-Xmxi1 together with X-ngnr-1 did not alter the
induction of early target genes of X-ngnr-1, such as Ebf2, X-
MyT1 and NeuroD or ESR9; however, X-ngnr-1-mediated
activation of the late target genes XEbf3, XPak3, and N-
tubulin was inhibited.Taken together, the results obtained thus far suggest that
Xmxi1 maintains an early neuronal precursor state in neural
ectoderm, resulting in the inhibition of neuronal differentiation
at the open neural plate stage. We next evaluated if this
inhibition was transient, as has been observed for SoxD (Yeo
and Gautier, 2005; Mizuseki et al., 1998). The ability of MT-
Xmxi1 to influence neural and neuronal differentiation markers
in both naive and neuralized animal caps was compared by use
of animal caps that were cultured until siblings had reached
stage 14 (early) or stage 20 (late) and analyzed by real-time RT-
PCR. As shown in Fig. 7A, in early animal caps, MT-Xmxi1
weakly induces Sox3 and Nrp-1 but did not significantly alter
the transcript levels of SoxD and NCAM. In contrast, the neural
inducer noggin strongly activates all four pan-neural markers.
Moreover, in early caps, noggin and Xmxi1 alone or in
combination did not induce X-ngnr-1 or N-tubulin. In late stage
MT-Xmxi1-injected caps, the levels of Sox3 and Nrp-1
declined, but those of SoxD and NCAM were not altered.
However, both X-ngnr-1 and N-tubulin were induced. The
activation of X-ngnr-1 and N-tubulin was even stronger when
Fig. 7. (A) Xmxi1 induces neuronal differentiation in neuralized late, but not early animal caps. Animal caps were harvested from embryos injected with noggin (50 pg)
and MT-Xmxi1 (500 pg), as indicated. At the equivalent of stage 14 or 20, the caps were harvested and analyzed by real-time RT-PCR. Expression levels were
normalized to ODC and compared to control caps, which were set to 1. (B–E) The inhibition of neuronal differentiation by Xmxi1 is only transient. At tailbud stages,
MT-Xmxi1 (750 pg) ectopic Sox3 is still present (B) and ectopic N-tubulin expression is also detected (D). (C, E) Transversal sections of B and D, respectively. Red
arrowhead marks ectopic expression.
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noggin alone did not strongly activate these markers.
To further confirm these results, we evaluated MT-Xmxi1-
injected embryos at the early tailbud stage. As shown in Figs.
7B–E, on the injected side, most embryos have small protrusions
suggesting Xmxi1 may also increase proliferation. The ectopic
Sox3 (45%, n = 32) staining observed at the open neural plate
stage persisted, with a reduced extent and percentage as
compared to early neurula stages. The inhibition of N-tubulin
was found to be transient as wild-type levels were observed on
the injected side of the neural tube. In addition, a limited amount
of ectopic N-tubulin staining was detected (60%, n = 25).
Interestingly, as shown byWestern blot analysis (Supplementary
Material), by stage 22, the MT-Xmxi1 protein is no longer
detectable, suggesting that high levels of Xmxi1, similar to
Sox3, may be incompatible with neuronal differentiation. At
lower Xmxi1 concentrations (5–50 pg), an increase in neuronal
differentiation was not observed (data not shown). However, at
these lower concentrations, Sox3 was also not induced.
Therefore, Xmxi1 can only induce a delayed neuronal
differentiation in neuralized tissue consistent with the animal
cap experiments.Effects of Xmxi1 on proliferation and apoptosis
To determine if Xmxi1 inhibits neuronal differentiation at
neurula stages by increasing proliferation as suggested by
inhibition of cell cycle regulator gene expression and activation
of Sox3, mitotic cells of MT-Xmxi1-injected embryos were
stained with the antibody against phosphorylated histone H3
(pH3). The number of pH3-positive cells in the neural plate of
the injected side was compared with the uninjected side in serial
sections. While sections from control embryos did not differ
significantly in the number of pH3-positive cells on each side of
the midline, overexpression of mRNA (500 pg) encoding for
MT-Xmxi1 and EnR-Xmxi1 almost doubled the number of pH3-
positive cells compared with the uninjected side (Fig. 8A). A
hormone-inducible version of Xmxi1, generated by fusion of the
ligand-binding domain of the glucocorticoid receptor (GR) to
the C-terminus of Xmxi1 (Xmxi1-GR), was created (Gammill
and Sive, 1997). Activation of this construct by treatment of the
injected embryos at stage 10.5 with dexamethasone induced
ectopic Sox3 and inhibition of neuronal differentiation (Fig. 8C),
as well as increased proliferation on the injected side (Fig. 8A).
Moreover, injection of the Xmxi1-MO, but not of the control-
Fig. 8. Xmxi1 induces proliferation in the open neural plate of Xenopus embryos. MT-Xmxi1 (500 pg), EnR-Xmxi1 (500 pg), and Xmxi1-GR (500 pg, induced at stage
10.5 with dexamethasone), Xmxi1-MO (12.5 ng), or the control-MO (Co-Mo) (12.5 ng) was injected in Xenopus embryos. Proliferation on the injected side compared
with the noninjected side was measured by counting (A) pH3 or (B) BrdU-positive cells of 15 consecutive sections of five embryos in the open neural plate region.
Shown is the average number of positive cells per section. Error bars indicate the standard error of the mean. (C) Forced cell cycle arrest does not alter the phenotype of
Xmxi1-injected embryos. In Xmxi1-GR-injected embryos, proliferation was blocked by HUA treatment at stage 10 and induced at stage 10.5 with dexamethasone. (D)
Inhibition of MT-XMxi1-induced apoptosis does not rescue loss of N-tubulin. Overexpression of MT-Xmxi1 (500 pg) led to an increase in apoptosis as seen by
TUNEL staining (upper panel, right). Coinjection of human Bcl2 mRNA (500 pg) blocked apoptosis (lower panel, right) but did not influence the effects of MT-Xmxi1
on Sox3 and N-tubulin.
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also injected a lower concentration to determine if the effect of
Xmxi1 on cell proliferation was maintained at lower concentra-
tions. However, injection of a low dose of MT-Xmxi1 (50 pg)
did not alter the number of pH3-positive cells on the injected side
or the expression of Sox3 and N-tubulin (data not shown).
As Mxi1 overexpression results in the accumulation of
glioblastoma and prostate carcinoma cells in the G2/M phase,
which would also result in an increase of pH3-positive cells, we
also measured BrdU incorporation to further evaluate the role of
Xmxi1 on proliferation (Manni et al., 2002; Taj et al., 2001;
Wechsler et al., 1997). Consistent with the results obtained by
pH3 staining, the MT-Xmxi1, EnR-Xmxi1 or Xmxi1-GR fusion
constructs nearly doubled the number of BrdU-positive cells on
the injected side, while the Xmxi1-MO, but not the control-MO,
decreased the number of positive cells (Fig. 8B).
These results suggest that Xmxi1 may maintain an
undifferentiated neural state by activation of proliferation. We
therefore asked if the ectopic Sox3 and inhibition of N-tubulin
expression as observed upon overexpression of Xmxi1 could beinhibited by forceful cell cycle arrest achieved through the
treatment of the injected embryos with a cocktail of hydroxy-
urea and aphidicolin (HUA) (Harris and Hartenstein, 1991). The
effectiveness of the inhibitors was verified by the failure of
embryos to gastrulate when treated at stage 8. Embryos treated
at stage 10 developed normally up to open neural plate stages
but exhibited strongly reduced pH3 staining, further demon-
strating the effectiveness of treatment (Fig. 8C). Ectopic Sox3
and inhibition of N-tubulin expression was still observed when
the Xmxi1-GR-injected embryos were treated with HUA at
stage 10 and induced with dexamethasone at stage 10.5 (−HUA,
ectopic Sox3, 72%, n = 19, inhibition N-tubulin 86%, n = 31;
+HUA, ectopic Sox3, 74%, n = 15, inhibition N-tubulin 76%,
n = 24). These results suggest that both the Xmxi1-mediated
induction of Sox3 and concomitant downregulation of N-
tubulin do not directly depend on an increase in cellular
proliferation.
An alternative mechanism for the absence of post-mitotic
neurons upon overexpression of Xmxi1 could be due to the loss
of these cells by apoptosis. The effect of Xmxi1 on programmed
Fig. 9. Scheme representing the role of Xmxi1 during primary neurogenesis in Xenopus. Neural induction by BMP inhibitors leads to the activation of several pan-
neural expressed genes including Sox3 and SoxD. In turn, SoxD can activate Xmxi1, which is required for SoxD-induced activation of NCAM, Nrp-1, X-ngnr-1, and
neuronal differentiation. Xmxi1 transiently inhibits neuronal differentiation downstream of the proneural genes (red dashed arrow), which may be the result of Sox3
activation. At later stages, Xmxi1 can induce neuronal differentiation (black dashed arrow). Xmxi1 is also activated by proneural genes such as X-ngnr-1 and NeuroD.
In the absence of Xmxi1, X-ngnr-1 does not completely neuralize the ectoderm, and neuronal differentiation is inhibited.
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by TUNEL staining. As shown in Fig. 8D, injection of mRNA
encoding for MT-Xmxi1 increased the amount of cells
undergoing apoptosis. The increased number of apoptotic
cells is most likely not sufficient to account for the loss of N-
tubulin expression. To address if Xmxi1-induced apoptosis
contributes to the activity of Xmxi1 during neurogenesis, MT-
Xmxi1 was coinjected with the apoptosis inhibitor Bcl2. Bcl2
alone slightly increased neuronal differentiation, as reported
previously (Yeo and Gautier, 2003) (data not shown). However,
coinjection of human Bcl2 (500 pg) with MT-Xmxi1 did not
alter the ability of MT-Xmxi1 to inhibit N-tubulin expression
but was sufficient to block MT-Xmxi1-induced apoptosis
(−Bcl2, ectopic Sox3, 76%, n = 34, inhibition N-tubulin 82%,
n = 25; +Bcl2, ectopic Sox3, 73%, n = 32, inhibition N-tubulin
84%, n = 25) (Fig. 8D). These results demonstrate that, while
both cell proliferation and apoptosis are induced by Xmxi1,
both activities appear not to be necessary for the activation of
Sox3 and inhibition of neuronal differentiation, suggesting that
Xmxi1 may have a direct influence on cell fate.
Discussion
In this study, we report on the identification of a novel
Xenopus Mad family member and its role in the context of
neurogenesis. Xmxi1 is expressed broadly throughout the
domains of primary neurogenesis during early embryogenesis,
and, at later developmental stages, the expression is maintainedthroughout the CNS. Consistent with the early expression of
Xmxi1 transcripts during Xenopus primary neurogenesis, we
have found that Xmxi1 plays an essential role in the formation
of a mature neural fate, which can be acted upon by factors that
induce neuronal differentiation.
A summary of the obtained results and the relationship of
Xmxi1 with known components of the neurogenesis network
are shown in Fig. 9. Consistent with an early role in the context
of neurogenesis, Xmxi1 was positively regulated by the pan-
neurally expressed HMG-box transcription factors Sox3 and
SoxD. Through loss-of-function experiments, Xmxi1 was
shown to be required for the endogenous expression of X-
ngnr-1 and consequently neuronal differentiation, as well as for
SoxD-induced activation of Nrp-1, NCAM, and X-ngnr-1.
While Xmxi1 is required for neurogenesis, overexpression of
Xmxi1 at high concentration inhibits neuronal differentiation,
which may be the result of Sox3 induction and maintenance of
an early neural cell fate. X-ngnr-1 and its early proneural target
genes, such as X-MyT1 and Ebf2, are not inhibited by
overexpression of Xmxi1, but the expression of late acting
differentiation genes such as Ebf3 and those required for cell
cycle withdrawal of the progenitors including XPak3 and p27
(Xic1) are inhibited. Suppression of neuronal differentiation is
only transient, and, at later developmental stages, the expanded
precursor population, perhaps due to a decline in concentration
of Xmxi1 or Sox3, can undergo neuronal differentiation. In
addition, Xmxi1 is also positively regulated by X-ngnr-1 and
NeuroD. While Xmxi1 may have an additional role downstream
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establishing a mature neural fate, which is required prior to the
initiation of neuronal differentiation. This hypothesis is
supported in animal cap experiments, whereby, in the absence
of Xmxi1, the complete neuralization of the ectoderm by X-
ngnr-1 as marked by Nrp-1 and NCAM is inhibited, as well as
neuronal differentiation.
Several prepattern genes have been identified that bridge the
events of neural induction with the downstream acting
proneural genes. However, the epistatic relationship and the
molecular mechanism by which these factors act are for the
most part unknown. Members of the SoxB1 and Zic families
have been found to participate in the early establishment and
stabilization of a neural fate. SoxD and members of the Xiro
family, in contrast, act as late stabilizing genes, positively
regulating the proneural genes and promoting neuronal
differentiation (Penzel et al., 1997; Kuo et al., 1998; Brewster
et al., 1998; Mizuseki et al., 1998; Bellefroid et al., 1998;
Gomez-Skarmeta et al., 1998). As only a restricted number of
cells within the neuroectoderm will exit the cell cycle and
commence differentiation (Hartenstein, 1989), one intriguing
question is how the three bilateral longitudinal primary
neurogenesis domains are selected by these broadly expressed
prepattern genes. Zic2 inhibits neuronal differentiation and may
contribute to this process, particularly at late neurula stages
where it is expressed in the posterior region of the neural plate in
domains that alternate with stripes of the proneural genes
(Brewster et al., 1998). However, during gastrulation and early
neurula stages, Zic2 is expressed broadly throughout the
prospective neural ectoderm (Brewster et al., 1998), suggesting
the involvement of additional factors.
Most identified proneural genes exhibit coordinated expres-
sion in the discrete domains of primary neurogenesis. The
temporal expression of the genes within these domains correlates
with their function. Early expressed genes tend to act as
determination factors while later expressed genes function in
differentiation. Moreover, a refinement of the proneural domains
is also observed. For example, the expression of X-ngnr-1 is
much broader than downstream differentiation factors such as X-
MyT1, which is expressed in slightly larger domains than N-
tubulin (Bellefroid et al., 1996). As described above, it remains
elusive as to how the known prepattern genes can account for the
restricted expression of the proneural genes. Based on the
expression of Xmxi1 and its requirement for SoxD function,
Xmxi1 is an ideal candidate to participate in this process.
In naive animal caps, the effectiveness of Xmxi1 in
promoting ectopic neuronal differentiation was low. However,
in neuralized animal caps, the ability of Xmxi1 to induce
neuronal differentiation was much stronger, suggesting the
existence of coacting factors such as SoxD and other prepattern
genes that act synergistically or in parallel. The gain-of-function
phenotype of Xmxi1 was similar to that of SoxD, i.e. the
transient inhibition of neuronal differentiation at the open neural
plate stage with ectopic neurons at the tailbud stage (Yeo and
Gautier, 2005; Mizuseki et al., 1998). Albeit, SoxD is much
more effective in inducing ectopic neuronal differentiation
compared with Xmxi1.In Xmxi1-injected embryos, at the open neural plate stage, an
inhibition of neuronal differentiation was observed concomitant
with ectopic activation of a marker of proliferating neural
progenitor cells, Sox3. A correlation of ectopic Sox3 activation
with inhibition of neuronal differentiation at the open neural
plate stage followed by ectopic neurogenesis at later stages has
been observed during primary neurogenesis in Xenopus
(Bellefroid et al., 1998; Voigt et al., 2005). Electroporation of
Sox2 and Sox3 in the chick neural tube has also been shown to
inhibit endogenous and X-ngnr-1-induced neurogenesis
(Bylund et al., 2003; Graham et al., 2003). The association of
Sox3 with proliferating cells has given rise to the idea that Sox3
promotes proliferation at the expense of differentiation.
However, a direct interaction of Sox3 with the cell cycle
machinery has not been established. Moreover, forced cell cycle
arrest with HUA could not rescue the ectopic Sox3 expression
and suppression of neuronal differentiation, suggesting that
Xmxi1, and possibly Sox3, have a direct influence on neural
cell fate specification.
The observation that Xmxi1 induces proliferation was
somewhat surprising as previous studies have demonstrated
that Mxi1, like other members of the Mad family, can induce
growth arrest and can antagonize Myc activity when over-
expressed in cell lines (Zervos et al., 1993; Schreiber-Agus et al.,
1995; Wechsler et al., 1997). From these studies and numerous
others, a model of the Myc-Max-Network has been established,
in which the Mad family of transcriptional repressors is thought
to function exclusively to attenuate and restrict Myc activity.
However, emerging evidence, predominately from in vivo
experiments, suggests that this elegant but simplistic model
needs to be reevaluated. The different Mad knockout mice
(Mad1, Mxi1, and Mad3), with the exception of Mnt, exhibited
only subtle effects on growth and differentiation and did not give
rise to tumors, as would be predicted if theMads were to function
as Myc antagonists in vivo (Sadaghiani and Thiebaud, 1987;
Toyo-oka et al., 2004; Grandori et al., 2000; Hurlin et al., 2003).
In addition, the Mad and Myc proteins are most likely to have
both shared and unique target genes (O'Hagan et al., 2000). The
expression of some members of the Mad family, such as Xmad1,
coincides with cells that have undergone terminal differentiation
(Gehring et al., 2000; Bejarano et al., 2000; Roussel et al., 1996;
Roy and Reisman, 1995; Pulverer et al., 2000; Juergens et al.,
2005). Mxi1, in contrast, is found in both proliferating (together
with Myc) and differentiating cells (Zervos et al., 1993; Larsson
et al., 1994; Hurlin et al., 1995). The situation for Mxi1 is further
complicated by the finding of multiple isoforms differing in their
ability to act as transcriptional repressors and to inhibit Myc
activity (Engstrom et al., 2004; Dugast-Darzacq et al., 2004).
The distinct domains of expression during Xenopus
embryogenesis described in this study and that of the previously
described Xmads suggest that members of the Mad family of
transcriptional repressors may have additional functions
independent from the ability to antagonize Myc activity
(Newman and Krieg, 1999; Juergens et al., 2005). Moreover,
the expression of Xmxi1 at neurula stages does not coincide
with Myc expression, which is found in the premigratory neural
crest cells and the anterior neural plate (Bellmeyer et al., 2003),
484 T.J. Klisch et al. / Developmental Biology 292 (2006) 470–485further suggesting a function for Xmxi1 during Xenopus
embryogenesis other than acting as an Myc antagonist.
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